SCHEMBL5764671

SCHEMBL5764671

CCC1(Cc2c(N)nc(C)nc2O)OCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5763401 0.82 GAA (0.36)
SCHEMBL5764595 0.78 DGAT1 (0.30)
SCHEMBL12819534 0.66
SCHEMBL12040852 0.63 MAPT (0.33)
SCHEMBL5561175 0.61 ALDH1A1 (0.31)
SCHEMBL1018739 0.60
SCHEMBL9362921 0.59 ESR1 (0.42)
SCHEMBL16938750 0.59 LMNA (0.32)
Hydrochloric Acid SCHEMBL5555790 0.59 ALDH1A1 (0.31)
SCHEMBL9632330 0.59 ALDH1A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1091738-B1 BICYCLIC sPLA 2 INHIBITORS LILLY CO ELI (US) 2006-12-06 EP disclosed
US-6384041-B1 ANTIINFLAMMATORY AGENT, TREATMENT OF SHOCK AND ENZYME INHIBITORS ELI LILLY AND COMPANY 2002-05-07 US disclosed